Search clinical trials for: Cytochrome P 450 CYP2D6 Variants

Total 496764 results

Abbott

Completed

Study in Healthy Adults to Evaluate Pharmacokinetics, Safety and Tolerability of ABT-450 With Ritonavir

HCV Infection

United States
Boehringer Ingelheim

Completed

Effect of Cytochrome P 450 3A4 Inhibition by Itraconazole on the Single Oral Dose Pharmacokinetics of Cilobradine

Healthy
Bristol-Myers Squibb

Withdrawn

A Study to Evaluate the Effect of Fluconazole, Bupropion, or Itraconazole on the Drug Levels and Safety of BMS-986235

Healthy Participants

United States
Central Finland Hospital District
Biosense Webster, Inc.

Unknown

Medical ANtiarrhythmic Treatment or Radiofrequency Ablation in Ischemic Ventricular Tachyarrhythmias (MANTRA-VT)

Myocardial Infarction | Ventricular Tachyarrhythmia

Finland
Washington University School of Medicine

Completed

Clinical Study of Generic and Brand Bupropion in Depression (BALANCE)

Major Depressive Disorder

United States
GlaxoSmithKline

Completed

Study In Patients With Depression Not Responding to Selective Serotonin Re-uptake Inhibitors

Depressive Disorder

Japan
IRCCS Policlinico S. Matteo

Terminated

Epigallocatechingallate (EGCG) in Cardiac AL Amyloidosis (EpiCardiAL)

Primary Amyloidosis of Light Chain Type

Italy
Hadassah Medical Organization

Unknown

A Brain Imaging Study Into Nicotine Induced Dopamine Release in Cigarette Smokers.

Tobacco Use Disorder

Israel
Teva Pharmaceuticals USA

Completed

90 mg Fluoxetine Hydrochloride Capsules Under Non-Fasting Conditions

Healthy

United States
Johns Hopkins University
National Institute of Mental Health (NIMH)

Completed

Study of Paroxetine and Fluconazole for the Treatment of HIV Associated Neurocognitive Disorder (ParaFlu)

HIV Associated Neurocognitive Disorder

United States
University of Nebraska

Completed

Bupropion in the Treatment of Methamphetamine Dependence

Methamphetamine Use Disorder

United States
University Health Network, Toronto
Sunnybrook Health Sciences Centre; University of British Columbia; University... and other collaborators

Completed

Fluoxetine Opens Window to Improve Motor Recovery After Stroke (FLOW)

Vascular Diseases | Stroke | Cerebrovascular Disorders | Brain Diseases | Central Nervous System Diseases | Nervous System Diseases | Brain Ischemia | Cerebral Infarction | Brain Infarction | Cerebrovascular Accident

Canada
Stanford University
GlaxoSmithKline

Completed

Treatment of Nicotine Dependence and Acute Depression

Major Depressive Disorder | Nicotine Dependence

United States
Children's Hospital Los Angeles
Patient-Centered Outcomes Research Institute

Active, not recruiting

Fluoxetine vs CBT in Childhood Anxiety Disorders (SMART)

Anxiety Disorders

United States
Yu-Li Hospital
National Health Research Institutes, Taiwan; Department of Health, Executive...

Completed

The Pharmacogenetic Study , Readiness to Change, and Pharmacological Intervention for Smoking Cessation in Schizophrenia (PSIAARP)

Schizophrenia | Tobacco Dependence

Taiwan
Massachusetts General Hospital
National Institute of Mental Health (NIMH)

Completed

Antidepressant Medication Plus Directly Observed Therapy for Improving Adherence to Antiretroviral Therapy

Depression | HIV Infections

United States
Centre Hospitalier St Anne

Terminated

"Evaluation by Transcranial Magnetic Stimulation of the Benefit of Fluoxetine on Motor Recovery After Stroke" (EFLUSTIM)

Cerebral Infarction

France
University of Arkansas
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)

Terminated

Bupropion for Depression in ESRD Patients on Hemodialysis

End Stage Renal Disease | Major Depression

United States
Capital Medical University

Completed

Comparison of Venlafaxine and Fluoxetine in the Treatment of Postmenopausal Women With Major Depression

Major Depression

China
Massachusetts General Hospital

Terminated

Extended Duration Nicotine Replacement Therapy and Bupropion in Smokers With Schizophrenia

Schizophrenia | Nicotine Dependence

United States
Dr. Reddy's Laboratories Limited

Completed

Bioequivalence Study of Fluoxetine Hydrochloride Delayed-Release Capsules, 90 mg of Dr. Reddy's Under Fasting Condition

Healthy

India
Xijing Hospital

Recruiting

Precise Transcranial Magnetic Stimulation for Post-traumatic Stress Disorder

PTSD

China
GlaxoSmithKline

Completed

Bioequivalence Study of Paroxetine Immediate Release (IR) Tablets Manufactured in GlaxoSmithKline Tianjin (GSKT) and Mississauga Sites in Healthy Chinese Subjects

Anxiety Disorders

China
GlaxoSmithKline

Completed

A Study Of A New Medicine (GW597599B) For The Treatment Of Major Depressive Disorder

Depressive Disorder, Major
New York State Psychiatric Institute
National Institute of Mental Health (NIMH)

Completed

Comparing Treatments for Self-Injury and Suicidal Behavior in People With Borderline Personality Disorder

Suicide | Borderline Personality Disorder

United States
Segraves, R., T., M.D., Ph.D.
GlaxoSmithKline

Completed

Female Orgasmic Disorder (FOD) and Wellbutrin XL

Orgasmic Disorder

United States
Oizumi Hospital

Unknown

Benefits of Switching Antidepressants Following Early Nonresponse

Depression

Japan
Geha Mental Health Center

Unknown

Comparative Study of SR Bupropion for Adolescent Smoking Cessation

Smoking | Smoking Cessation

Israel
U.S. Army Medical Research and Development Command
PPD; Idorsia Pharmaceuticals Ltd.; Berry Consultants; Cambridge Cognition Ltd; Ci...

Recruiting

Department of Defense PTSD Adaptive Platform Trial Intervention A - Fluoxetine

Post Traumatic Stress Disorder

United States
Yale University
National Institute of Mental Health (NIMH)

Recruiting

Brain Network Changes Accompanying and Predicting Responses to Pharmacotherapy in OCD

Obsessive-Compulsive Disorder

United States
Mylan Pharmaceuticals Inc

Completed

Fasting Study of Fluoxetine Capsules 40 mg and Prozac Pulvules 40 mg

Healthy

United States
Jiangsu HengRui Medicine Co., Ltd.

Unknown

Drug-drug Interaction of SHR3680 With Repaglinide and Bupropion

Prostate Cancer Patients

China
University of North Carolina, Chapel Hill
National Institute on Alcohol Abuse and Alcoholism (NIAAA)

Completed

Buproprion for Binge Drinking

Alcohol Abuse

United States
Hospital de Clinicas de Porto Alegre

Completed

Randomized Clinical Trial of a Mindfulness Based Intervention in Generalized Anxiety Disorder

Generalized Anxiety Disorder

Brazil
Vanderbilt University Medical Center

Completed

Dynamic Measures of Neurochemistry in Mood Disorders

Depression

United States
Donaghue Medical Research Foundation
Yale University

Completed

Comparison of Fluoxetine, Calcium and Placebo for the Treatment of Moderate to Severe Premenstrual Syndrome (PMS)

Premenstrual Syndrome

United States
Charite University, Berlin, Germany
University Hospital Muenster; Ruhr University of Bochum; University of Ulm

Completed

Apathy Cure Through Bupropion in Huntington's Disease (Action-HD)

Huntington's Disease | Apathy

Germany
Dr. Reddy's Laboratories Limited

Completed

Bioequivalence Study of Fluoxetine Hydrochloride Delayed-Release Capsules 90 mg of Dr. Reddy's Under Fed Condition

Healthy

India
Germans Trias i Pujol Hospital

Not yet recruiting

Precision Psychiatry for Depression: Immune Response and Affective Symptoms as Predictors of Response to Antidepressants (LYMPHODEP)

Depression | Inflammation | Immunity | Antidepressants

Spain
McMaster University
Hamilton Health Sciences Corporation

Completed

The Gut Microbiota in Obsessive-Compulsive Disorder

Obsessive-Compulsive Disorder

Canada
VA Office of Research and Development

Active, not recruiting

Multiphase Optimization Trial of Incentives for Veterans to Encourage Walking

Depression | Hypertension | Exercise | Sedentary Behavior | Motivation | Walking | Body Mass Index

United States
Ipsen

Completed

Real-world Treatment Patterns and Outcomes Among aRCC Patients on Cabozantinib or Axitinib in England

Renal Cell Carcinoma

United Kingdom
University College Dublin
Irish Research Council

Completed

CopeSmart: Using Mobile Technology to Promote Positive Mental Health in Young People

General Mental Health and Well-Being

Ireland
University of Roma La Sapienza

Unknown

Nutraceuticals to Improve Lipid Profile in European Countries (PIN)

Hyperlipidemia

Italy
New York State Psychiatric Institute

Completed

Dichotic Listening as a Predictor of Medication Response in Depression

Major Depression | Dysthymia | Depressive Disorder Not Otherwise Specified

United States
National Institute of Mental Health (NIMH)

Completed

Clonazepam and Paroxetine for Rapid Treatment of Post-Traumatic Stress Disorder

Post Traumatic Stress Disorder

United States
University of Göttingen
GlaxoSmithKline

Completed

Paroxetine vs Placebo Combined With Aerobic Exercise or Relaxation in Panic Disorder (Exparox)

Panic Disorder

Germany
Aclaris Therapeutics, Inc.

Terminated

Study of ATI-450 in Patients With Cryopyrin-Associated Periodic Syndrome (CAPS)

Cryopyrin-Associated Periodic Syndrome

United States
Mayo Clinic
National Institute on Alcohol Abuse and Alcoholism (NIAAA)

Completed

Pharmacologic Relapse Prevention for Alcoholic Smokers

Smoking | Alcoholism

United States
University of Central Florida
National Institute of Mental Health (NIMH)

Completed

Treatment of Childhood Social Phobia

Social Phobia

United States

Search clinical trials for: Cytochrome P 450 CYP2D6 Variants

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Trinidad & Tobago

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations